Cadre's Nuclear-Safety Pivot and a Raised Guide Meet a 26% Drawdown
Record backlog, an FBI ballistic-panel win, and a fresh M&A cadence underpin raised 2026 guidance — but the stock still trades a quarter below its peak.
CDRE · Earnings Call · 2026-08-06
Cadre Holdings closed its second quarter with the kind of numbers most small industrials only dream of — 32% net sales growth, 56% adjusted EBITDA growth, a record order backlog for a second consecutive quarter, and a raised full-year guide implying ~24% revenue and ~27% EBITDA growth. Yet the stock sits roughly 26% below its March 2026 peak. The gap between Cadre's operational momentum and the market's apparent skepticism is where the real story lives.
The nuclear vertical gets real
The most consequential development on the call was the maturation of the nuclear-safety platform. President Brad Williams walked through the three-segment thesis — environmental remediation (still 50-60 years of work), national defense (the NNSA budget request of $32.8B, up 29% year-over-year), and the commercial nuclear renaissance that's the "cherry on top." The company's keyword trajectory for the quarter is dominated by environmental remediation and commercial nuclear, matching what other reporters like CEG and BWXT echoed — a government-funded nuclear build-out that the market is increasingly tagging. Crucially, this isn't just hope: nuclear backlog grew $13M since year-end, driven by commercial nuclear energy and environmental remediation in both the U.S. and Northern Europe.
Two specific wins anchor the quarter. The Med-Eng BEMO blast-exposure monitoring program pulled in a second purchase order worth $8.4M, bringing the total to $18.4M against a $50M IDIQ — Brad called it "a testament to Med-Eng's ability to develop best-in-class products that keep users safe in the line of duty." The larger strategic statement is the Safariland SXHP ballistic panel, selected by the FBI over 11 competing products for the Predictive Ballistics overt-armor kit — a 5-year, $61M IDIQ. This is a beachhead into the federal law-enforcement complex beyond the traditional state/local channels.
M&A spins faster, but stays disciplined
Warren Kanders was explicit that M&A "remains a critical component of our long-term growth strategy." Since IPO, Cadre has spent ~$455M across 7 deals, capped by TYR Tactical (the largest since going public) and this quarter's Alien Gear bolt-on. Alien Gear, a holster brand bought out of bankruptcy, did ~$4.8M in the quarter — "ahead of expectations" — and management was careful not to over-model it. Blaine Browers said they "have not baked into the guide at $11 million" and remain cautious "to make sure there's no overhang coming out of bankruptcy." The integration playbook is familiar: fold the consumer side into Safariland's teams, close the Idaho facility, and migrate manufacturing over 12-18 months, pushing margins toward "Cadre type" levels. That's the Alien Gear team execution in miniature.
The EBITDA growth engine gets real lift here. Blaine noted net leverage at 2.5x against a stated 3.5x ceiling — with the right tuck-in at "post synergy" economics being very compelling at the small end, and dry powder for larger deals in the back half. This pairs with strong free cash flow (the fundamentals show FCF margin oscillating in the 10-12% range) and a track record of paying down debt between acquisitions.
Fundamentals vs. the tape: a drawdown disconnect
Here's the tension. The just-filed 10-Q (period-end May 1) shows a soft quarter: operating income down 45% yoy, net income down 79%, gross margin at 38.7% (down 4.4pp). Management's explanation has been consistent — Q1 was a "tougher quarter based on volume and mix," with the back half normalizing. Q2 largely confirmed that: gross margin 42.6%, and 43.8% excluding inventory step-up.
So why the drawdown? The full-history tape shows a -25.9% peak-to-trough from the March 2026 high of $46.07, with only +4.5% in the last 90 days — the market has been de-rating the name even as fundamentals improve. Q1's 4.8% operating margin was a stark reminder that this model carries real quarterly volatility — large, lumpy government orders (EOD suits, blast seats, nuclear systems) make the reported numbers look worse than the run-rate economics.
The market is also absorbing real leverage creep. Effective net cash went from -$182M to -$322M as TYR and Alien Gear landed. The balance sheet still has headroom — net leverage 2.5x vs. 3.5x ceiling — but the equity's valuation (2.1x price-to-revenue) is reflecting both growth optionality and execution risk.
Why it matters
Cadre has quietly wedged itself into two of the most durable spending trends of this decade: AI/data-center-driven nuclear demand and a rearmament/proliferation of law-enforcement and military safety gear. The FBI panel win, the BEMO sensor follow-on, and the record backlog are the kind of M&A funnel catalysts that compound. The drawdown looks like a mix of the Q1 miss and rate-tightening-driven de-rating — not a thesis break. As Brad put it, "public safety spending has historically proven very resilient," and the nuclear backlog build "represents an important forward indicator."
The bears' best argument: the leverage ceiling at 3.5x means the big-ticket M&A optionality is actually thin — Blaine admitted "we've said our upper end of leverage is really 3.5," and getting to 3x requires fast paydown. So Cadre is more likely to do tuck-ins than a transformative deal before it delevers. That's fine — the compound story is already intact.